Addressing Immunogenicity for Implantable Drug-delivery Devices and Long-acting Injectables, Including Pharmacokinetic and Pharmacodynamic Correlations
用户aKgJC6g3RnhA
1个月前
70
10
已完结
1. 系统已在2025-05-15 10:58:55对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
J Matriano
2021
books.rsc.org
… , PD, and PK of ITCA 650 in patients with T2D was performed. … µg per day of the ITCA 650 implant placed subcutaneously for … of ITCA 650 in subjects with T2D treated for up to 48 weeks. …
